Takhzyro
RxNorm concept 2055646, brand name (bn).
- RxCUI
- 2055646
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2055646 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- lanadelumab-flyo (PIN, has precise ingredient)
- lanadelumab-flyo 150 MG/ML [Takhzyro] (SBDC, ingredient of)
- lanadelumab Injection [Takhzyro] (SBDF, ingredient of)
- Takhzyro Injectable Product (SBDG, ingredient of)
- 2 ML lanadelumab-flyo 150 MG/ML Injection [Takhzyro] (SBD, ingredient of)
- lanadelumab Prefilled Syringe [Takhzyro] (SBDF, ingredient of)
- 2 ML lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro] (SBD, ingredient of)
- 1 ML lanadelumab-flyo 150 MG/ML Prefilled Syringe [Takhzyro] (SBD, ingredient of)
- lanadelumab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2055646 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2055646 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2055646. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.